A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease

Condition:   ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease Interventions:   Drug: ALN-AAT02;   Drug: Placebo Sponsor:   Alnylam Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials